Adia Med: CEO buys 7% of Adia Labs for $350,000.00

What happened Adia Med filed a Current Report on Form 8-K on Oct 19, 2026 reporting that it entered into a Membership Interest Purchase Agreement dated on or about Oct 13, 2026 under which the Company sold seven (7) units of membership interest in Adia Labs LLC to Larry A. Powalisz, the Company’s Chief Executive Officer (the Buyer), for an aggregate purchase price of $350,000.00, payable in cash.

Key details

• The Purchased Units constitute a seven percent (7%) membership interest in the LLC and carry seven percent (7%) of the total voting power, assuming one hundred (100) issued units at closing.
• The Agreement requires the Company’s operating agreement to be amended at closing to reflect the Purchased Units and voting power.
• Proceeds from the Purchase Price may be used for Company or Seller corporate purposes only as jointly approved in writing by both independent directors, Monica Sher, M.D., and Richard Edwards, D.O.; the Buyer has no unilateral authority over use of the proceeds.
• The Buyer is a related party of the Company as its Chief Executive Officer; the independent directors acknowledged the Agreement.

Why it may matter This filing reports Item 1.01 — entry into a material definitive agreement, which discloses the membership interest sale and related-party aspects of the transaction. The filing does not show why the insider traded or why the company acted.